Avirmax CMC Inc. Successfully Delivers GMP Lots of AAV Vector Products for Client's Phase I/IIa Clinical Trial in the US This milestone marks a significant achievement in Avirmax CMC's mission to ...

CBM to provide Asimov's clonal HEK293 viral vector production platform to clients for preclinical and clinical manufacturing Clonal HEK293 suspension cell line is GMP-banked and qualified ...

Lonza enters the viral based-manufacturing market with its purchase of Vivante GMP Solutions, Inc. The acquisition advances ... Vivante’s experience with pre-clinical through late-stage supply of ...